Retinitis Pigmentosa (Retinitis) - Pipeline Insight, 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 50
Price : Single User: US $ 1250  US $ 1000 Corporate User: US $ 4000  US $ 2400
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Retinitis Pigmentosa (Retinitis)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Retinitis Pigmentosa (Retinitis). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Retinitis Pigmentosa (Retinitis) by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Retinitis Pigmentosa (Retinitis)

  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Retinitis Pigmentosa (Retinitis)

  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information

  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinitis Pigmentosa (Retinitis)

  • The report also covers the dormant and discontinued pipeline projects related to the Retinitis Pigmentosa (Retinitis)

Reasons to Buy

  • Establish comprehensive understanding of the pipeline activity across this Retinitis Pigmentosa (Retinitis) to formulate effective R&D strategies

  • Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine

  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Retinitis Pigmentosa (Retinitis) therapeutics

  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Retinitis Pigmentosa (Retinitis) - Pipeline Insight, 2017

Table of Contents

1. Report Introduction

2. Retinitis Pigmentosa (Retinitis) Overview

3. Pipeline Therapeutics
An Overview of Pipeline Products for Retinitis Pigmentosa (Retinitis)

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Total Products for Retinitis Pigmentosa (Retinitis)
Table 2: Products in Clinical Stage
Table 3: Products in Pre-Clinical and Discovery Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List of Figures

Figure 1:Total Products for Retinitis Pigmentosa (Retinitis)
Figure 2: Products in Clinical Stage
Figure 3: Products in Pre-Clinical and Discovery Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
  • Global Latanoprost Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Latanoprost market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Latanoprost in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • United States Eye Drops & Lubricants Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Eye Drops & Lubricants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth r......
  • Global Sustained Release Ocular Drug Delivery Systems Market Professional Survey Report 2017
    Published: 12-Dec-2017        Price: US 3500 Onwards        Pages: 118
    This report studies Sustained Release Ocular Drug Delivery Systems in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - pSivida - Allergan - Icon Bioscience ......
  • China Artificial Tears Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 08-Dec-2017        Price: US 4480 Onwards        Pages: 124
    This report studies the Artificial Tears market, Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. Scope of the Report: This report focuses on the Artificial Tears in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Seg......
  • Global Eye Drops & Lubricants Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Eye Drops & Lubricants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Eye Drops & Lubricants for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • United States Ophthalmic Therapeutic Drugs Market Report 2017
    Published: 06-Dec-2017        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gr......
  • China Conjunctivitis Market Research Report 2017
    Published: 06-Dec-2017        Price: US 3400 Onwards        Pages: 112
    The global Conjunctivitis market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Conjunctivitis development status and future trend in China, focuses on top players in China, also splits Conjunctivitis b......
  • United States Latanoprost Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 05-Dec-2017        Price: US 4480 Onwards        Pages: 119
    "Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressur......
  • Global Ophthalmic Therapeutic Drugs Sales Market Report 2017
    Published: 01-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Ophthalmic Therapeutic Drugs for these regions, from 2012 to 2022 (forecast) , covering - United States - China ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs